Enalapril Maleate Tablets — Class II drug recall D-1180-2022
Ongoing recall by Golden State Medical Supply Inc., reported 2022-07-13, distributed nationwide. CGMP Deviations
| Recall number | D-1180-2022 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Golden State Medical Supply Inc., Camarillo, CA, United States |
| Recall initiated | 2022-03-16 |
| Classified | 2022-07-07 |
| Reported by FDA | 2022-07-13 |
| Distributed | Nationwide (US) |
| Quantity | 1,424 bottles |
| Reason classes | cgmp |
| NDC | 60429-0183, 60429-0183-10, 60429-0183-30, 60429-0183-90, 60429-0184, 60429-0184-10, 60429-0184-30, 60429-0184-90, 60429-0185, 60429-0185-10, 60429-0185-30, 60429-0185-90, 60429-0186, 60429-0186-10, 60429-0186-30, 60429-0186-90 |
| Lot numbers | GS035031, GS035199, GS036495, GS036904, GS037401, GS037986, GS038359, GS039560, GS041110 |
| Expiration dates | 2022-03, 2022-05, 2022-09, 2022-11, 2022-12 |
Product
Enalapril Maleate Tablets, USP; 20 mg; 90 tablets, NDC 60429-186-90; manufactured by Taro Pharmaceutical Industries, Ltd.; packaged by GSMS, Incorporated, CA.
Reason for recall
CGMP Deviations
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1180-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.